ENG Gene Variant rs1085307433: Understanding HHT Associations
The rs1085307433 variant is located within the ENG gene, which provides instructions for making the endoglin protein. This specific genetic change is associated with hereditary hemorrhagic telangiectasia (HHT), a condition characterized by abnormal blood vessel development.
What each genotype means
Typical ENG genotype
This genotype represents the common, non-pathogenic state for this specific location in the ENG gene. It is not associated with the development of hereditary hemorrhagic telangiectasia (HHT) type 1.
This is the most common genotype found in the general population across all ancestries.
Potential HHT risk variant
This genotype includes one copy of the A allele, which has been identified in clinical research as a pathogenic variant associated with hereditary hemorrhagic telangiectasia (HHT) type 1. Because HHT is an autosomal dominant condition, individuals with this variant should consult with a genetic counselor or physician to discuss clinical screening and family history, as the presence of this variant is linked to the development of vascular anomalies.
This genotype is extremely rare in the general population, consistent with the low prevalence of HHT.
High-risk HHT genotype
This genotype indicates the presence of two copies of the A allele, which is associated with hereditary hemorrhagic telangiectasia (HHT) type 1. Individuals with this genotype are at a significantly increased risk for vascular dysplasia and should seek evaluation from a medical specialist familiar with HHT to discuss appropriate monitoring and management.
This genotype is exceptionally rare and is not typically observed in the general population.
Understanding the ENG Gene and rs1085307433
The ENG gene is responsible for producing endoglin, a protein that acts as a co-receptor for transforming growth factor-beta (TGF-beta) signaling. This pathway is essential for maintaining the structural integrity of blood vessels throughout the body. The variant rs1085307433 represents a specific change in the DNA sequence of this gene. When a variant occurs in ENG, it can disrupt the production or function of the endoglin protein, potentially leading to vascular instability. Because the gene is critical for endothelial cell function, variations here are closely monitored by researchers studying hereditary vascular disorders. Understanding where this SNP sits within the gene helps scientists determine if the change might interfere with protein folding or the signaling pathways necessary for healthy blood vessel formation.
Association with Hereditary Hemorrhagic Telangiectasia
Hereditary hemorrhagic telangiectasia (HHT), also known as Rendu-Osler-Weber syndrome, is an autosomal dominant disorder. It is characterized by the development of telangiectasias—small, dilated blood vessels—and larger arteriovenous malformations (AVMs) in organs such as the brain, lungs, and liver. Research indicates that pathogenic variants in the ENG gene are a primary cause of HHT type 1. The evidence linking specific variants in this gene to the condition is considered moderate to strong, as these mutations often lead to haploinsufficiency, where the body does not produce enough functional endoglin protein to maintain normal vascular health. Clinical manifestations often include recurrent nosebleeds, anemia, and potential complications from AVMs. Because HHT can have variable expressivity, even individuals with the same genetic variant may experience different symptoms.
Population Frequency and Clinical Context
The rs1085307433 variant is classified as rare in the general population. Large-scale genomic databases like gnomAD are frequently used to estimate the prevalence of such variants. While HHT itself is estimated to affect approximately 1 in 5,000 individuals, many cases remain underdiagnosed due to the subtle nature of early symptoms. It is important to note that the presence of a rare variant does not automatically confirm a clinical diagnosis of HHT. Genetic testing for HHT is typically performed in a clinical setting, often involving a multigene panel that includes ENG, ACVRL1, and SMAD4. Because the condition is autosomal dominant, family history plays a significant role in clinical assessment. If you have concerns about your genetic risk or family history, it is essential to consult with a genetic counselor or a specialist familiar with vascular disorders.
Navigating Genetic Information
Genetic information regarding variants like rs1085307433 is intended for educational purposes and should not be used for self-diagnosis. If you have received results indicating the presence of this variant, you should discuss these findings with a qualified healthcare provider. A clinician can interpret the results in the context of your personal and family medical history, physical examinations, and other diagnostic tests. They can also provide guidance on appropriate screening protocols if a diagnosis of HHT is suspected. Never make changes to your medical care or lifestyle based solely on a genetic report without professional medical advice. Genetic testing is a powerful tool, but it is most effective when integrated into a comprehensive clinical evaluation by experts who understand the complexities of hereditary vascular conditions.
How common is this variant?
The rs1085307433 variant is considered rare across all major ancestral populations, with a very low minor allele frequency observed in global genomic databases.
Frequently asked questions
What is hereditary hemorrhagic telangiectasia?
HHT is a genetic disorder that causes abnormal connections between arteries and veins, known as arteriovenous malformations. These can occur in various organs and often lead to symptoms like frequent nosebleeds and internal bleeding.
Is rs1085307433 a definitive test for HHT?
No, a single SNP result is not a clinical diagnosis. HHT is diagnosed through a combination of clinical criteria, family history, and comprehensive genetic testing interpreted by a medical professional.
What should I do if I have this variant?
You should schedule an appointment with a genetic counselor or a specialist in vascular medicine. They can help determine if the variant is clinically significant for you and discuss appropriate screening or monitoring.
Are there treatments for HHT?
While there is no cure for the underlying genetic cause, treatments exist to manage symptoms and prevent complications. These include procedures to treat bleeding or malformations, which should be discussed with your doctor.
Sources & further reading
Educational information only, last refreshed 10/1/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs1085307433?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in ENG
Genetic variant identified in the ENG gene, relevant for clinical screening of vascular disorders.
A known pathogenic mutation in the ENG gene linked to vascular malformations.
Pathogenic variant in the ENG gene associated with hereditary hemorrhagic telangiectasia type 1.
A variant in the ENG gene potentially impacting protein function related to vascular development.
This variant is located within the ENG gene, which is associated with hereditary hemorrhagic telangiectasia.
Clinically significant variant in the ENG gene associated with hereditary hemorrhagic telangiectasia.